Michael A. Panzara - Jul 25, 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Medical Officer, Head of Therapeutics Discovery and Development
Signature
/s/ Michael A. Panzara
Stock symbol
WVE
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4
Date filed
7/27/2022, 09:05 PM
Previous filing
May 27, 2022
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +60K $0.00 60K Jul 25, 2022 Ordinary Shares 60K $2.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 50% of the shares on July 25, 2023 and 50% on July 25, 2024.

Remarks:

Chief Medical Officer, Head of Therapeutics Discovery and Development